Cagrilitide 5mg

Description

Next-Generation Amylin Analogue & Metabolic Regulator

Ignite Labs Cagrilitide (5mg) is a long-acting synthetic analogue of the hormone amylin. In the landscape of metabolic research, Cagrilitide is a highly sought-after compound for its role in regulating energy balance and glucose homeostasis. Unlike GLP-1 agonists, Cagrilitide operates via the amylin receptors to signal early satiety, making it a critical focus for studies involving multi-pathway weight management and metabolic synergy.

Primary Research Applications

• Appetite & Satiety Signaling: Investigating the activation of amylin receptors in the hindbrain to reduce food intake and promote a feeling of fullness.

• Gastric Emptying Regulation: Studying the peptide’s ability to slow the rate at which food leaves the stomach, leading to more stable post-meal glucose levels.

• Synergistic Metabolic Research: Examining the effects of Cagrilitide when studied alongside GLP-1 receptor agonists (such as Semaglutide) for enhanced metabolic outcomes.

• Glucagon Suppression: Analyzing the peptide’s role in inhibiting inappropriate glucagon secretion, a key factor in maintaining healthy blood sugar levels.

• Energy Expenditure: Exploring how amylin analogues influence resting energy expenditure and lipid metabolism in metabolic models.

Product Specifications

• Concentration: 5mg Lyophilized Powder

• Purity Grade:  99%

• Molecular Profile: Acylated peptide optimized for extended half-life and stability.

• Quality Guarantee: Manufactured to the highest standards to ensure experimental reproducibility and precise data.

Disclaimer: This product is intended for laboratory research use only. It is not approved for human consumption, medical, or diagnostic use.